A股異動 | 華鐵應急(603300.SH)漲7% 推股權激勵計劃獲券商看好
格隆匯6月4日丨華鐵應急(603300.SH)股價觸及漲停價後回落,現報9.3元,漲幅6.9%,最新總市值84億。國盛證券指,公司發佈2021年股票期權激勵計劃(草案),擬激勵包括董事、高級管理人員以及核心技術/業務人員共812人,合計授予股票期權4466萬份,佔公司總股本4.95%。本次激勵行權價格10.50元/股,較當前股價溢價幅度高達21%,激勵彰顯強烈信心。預測2021-2023年公司歸母淨利潤分別為4.6/6.5/9.1億元,同增42%/41%/40%,考慮到本次股權激勵劃定中期高增長目標,公司規模、管理、渠道等優勢突出,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.